The study indicated that NAFLD and higher ALT levels were risk factors for fasting insulin and C-peptide, but not for fasting glucose, suggesting a potential direct influence of fatty liver on elevated insulin levels and an indirect effect on blood sugar through insulin and various metabolic markers. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.